Delta-Tocotrienol Combined with Standard Therapy May Increase Survival in Ovarian Cancer Patients
A recent study conducted at Denmark’s Vejle Hospital, published in Pharmacological Research, provided evidence of delta-tocotrienol’s benefits for cancer patients.